EFFECTS OF SERINE-PROTEASE INHIBITOR FOY-305 AND HEPARIN ON THE GROWTH OF SQUAMOUS-CELL CARCINOMA

Citation
M. Ohkoshi et al., EFFECTS OF SERINE-PROTEASE INHIBITOR FOY-305 AND HEPARIN ON THE GROWTH OF SQUAMOUS-CELL CARCINOMA, Anticancer research, 13(4), 1993, pp. 963-966
Citations number
33
Categorie Soggetti
Oncology
Journal title
ISSN journal
02507005
Volume
13
Issue
4
Year of publication
1993
Pages
963 - 966
Database
ISI
SICI code
0250-7005(1993)13:4<963:EOSIFA>2.0.ZU;2-P
Abstract
Effects of serine proteinase inhibitor FOY-305 and heparin on autochth onous skin carcinoma were examined using ddY female mice with single t umor induced by methylcholanthrene. FOY-305 given intraperitoneally fo r 9 consecutive weeks inhibited the growth of the pre-existing dermal tumors. Heparin alone was equally therapeutically effective. However, heparin induced severe mucocutaneous bleeding of the gastrointestinal mucosa. In contrast, the combined administration of FOY-305 and hepari n suppressed tumor growth without any visible side effects. There was a significant increase in well differentiated cancer cells in mice tre ated with FOY-305 and heparin in combination, suggesting that co-admin istration of FOY-305 and heparin may be useful for the treatment of sq uamous cell carcinoma.